MedPath

ORBUSNEICH MEDICAL, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Study of Vascular Healing With the Combo Stent Versus the Everolimus Eluting Stent in ACS Patients by Means of OCT

Phase 2
Completed
Conditions
Coronary Artery Disease
Acute Coronary Syndrome (ACS)
Atherosclerosis
Myocardial Infarction (MI)
Interventions
Device: PTCA with stent placement
First Posted Date
2011-07-29
Last Posted Date
2014-03-24
Lead Sponsor
OrbusNeich
Target Recruit Count
60
Registration Number
NCT01405287
Locations
🇫🇮

Satakunta Central Hospital, Pori, Finland

🇨🇭

University Hospital Zurich, Zurich, Switzerland

🇧🇪

AZ Middelheim, Antwerp, Belgium

and more 3 locations

Safety and Effectiveness Study of Combo Bio-engineered Sirolimus Eluting Stent

Phase 2
Completed
Conditions
Coronary Artery Lesions
Interventions
Device: coronary stenting
First Posted Date
2009-08-28
Last Posted Date
2016-03-29
Lead Sponsor
OrbusNeich
Target Recruit Count
180
Registration Number
NCT00967902
Locations
🇦🇺

John Hunter Hospital, Newcastle, New South Wales, Australia

Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth

Phase 4
Completed
Conditions
Coronary Artery Stenosis
Coronary Artery Disease
First Posted Date
2006-07-10
Last Posted Date
2014-04-08
Lead Sponsor
OrbusNeich
Target Recruit Count
100
Registration Number
NCT00349895
Locations
🇦🇹

Medizinische Universitätsklinik, Graz, Austria

🇧🇪

AZ Middelheim, Antwerp, Belgium

🇧🇪

OLV Ziekenhuis Aalst, Aalst, Belgium

and more 12 locations
© Copyright 2025. All Rights Reserved by MedPath